Glioblastoma (GBM) is a heterogenous primary brain tumour that is characterised with
unfavourable patient prognosis. The identification of biomarkers for managing brain …

Glioblastoma multiforme (GBM) is a highly heterogenic and malignant brain tumour with a
median survival of 15 months. The initial identification of primary glioblastomas is often …

Simple Summary Glioblastomas are brain tumors with a poor prognosis, and early tumor
progression occurs often. Therefore, patients are closely monitored with regular MRI scans …

Glioblastoma multiforme (GBM) is an aggressive brain malignancy characterised by its
invasive nature. Current treatment has limited effectiveness, resulting in poor patients' …

Letter to the editor regarding “Systematic review of research, mentorship, and career resources
for medical students pursuing neurosurgical training” - Enlighten Publications Skip to main …